Page 53 - தகவல்கள் பாதுகாப்பு கண்காணிப்பு பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Polyphor Announces Third Positive Data Safety Monitoring Board (DSMB) Recommendation to Continue Phase III balixafortide FORTRESS Study Without Modifications
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Switzerland Exercises Increased Option for 7 5 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca Clarifies: Vaccine Shown to Be 76% Effective in Results From US Clinical Trial PopSugar 3/25/2021 Samantha Brodsky © Getty / kuniharu wakabayashi AstraZeneca Clarifies: Vaccine Shown to Be 76% Effective in Results From US Clinical Trial
Update, March, 25, 2021: After pushback from US health officials and the National Institute of Allergy and Infectious Diseases claiming AstraZeneca referenced outdated information for interim analysis of vaccine efficacy in the phase 3 US clinical trial on Monday, the company released updated metrics stating the two-dose COVID-19 vaccine candidate proved to be 76 percent effective in preventing symptomatic COVID-19. This is slightly lower than 79 percent, the metric initially released. The company maintains that the shot is 100 percent effective against severe disease and hospitalization (a good sign).